Internet-Delivered, Therapist-Assisted Treatment for Anxiety and Depression in Patients with Cardiovascular Disease: Evidence-Base and Challenges
- PMID: 37119450
- DOI: 10.1007/s11886-023-01867-w
Internet-Delivered, Therapist-Assisted Treatment for Anxiety and Depression in Patients with Cardiovascular Disease: Evidence-Base and Challenges
Abstract
Purpose of review: This review focuses on the efficacy of internet-based psychological interventions for patients with cardiovascular disease (CVD) and comorbid anxiety and depression. Anxiety and depression comprise barriers for treatment adherence and are associated with poorer patient-reported and clinical outcomes, and greater health care costs.
Recent findings: Internet-based, therapist-assisted interventions targeting anxiety and depression can be as efficacious as face-to-face therapy and may have some advantages, as patients can do it from their own laptop/smartphone at home at a time of their convenience, which may facilitate a better integration in their lives. To enhance the field of internet-based therapy for patients with CVD, we need to involve patients in the development of interventions, focus on developing standards for adherence and assessment of fidelity, and assess and augment health literacy in patients to safeguard equality in health care.
Keywords: Anxiety; Cardiac rehabilitation; Cardiovascular disease; Depression; Internet-based therapy; Treatment.
© 2023. The Author(s), under exclusive licence to Springer Science+Business Media, LLC, part of Springer Nature.
References
Papers of particular interest, published recently, have been highlighted as: • Of importance •• Of major importance
-
- Frydensberg VS, Johansen JB, Moller S, Riahi S, Wehberg S, Haarbo J, et al. Anxiety and depression symptoms in Danish patients with an implantable cardioverter-defibrillator: prevalence and association with indication and sex up to 2 years of follow-up (data from the national DEFIB-WOMEN study). Europace. 2020;22(12):1830–40. https://doi.org/10.1093/europace/euaa176 . - DOI - PubMed
-
- • Pedersen SS, Nielsen JC, Wehberg S, Jorgensen OD, Riahi S, Haarbo J, et al. New onset anxiety and depression in patients with an implantable cardioverter defibrillator during 24 months of follow-up (data from the national DEFIB-WOMEN study). Gen Hosp Psychiatry. 2021;72:59–65. https://doi.org/10.1016/j.genhosppsych.2021.07.003 . Findings from this study show that 14.5% of patients with an implantable cardioverter defibrillator develop new-onset anxiety and 11.3% new-onset depression during 24 months of follow-up. - DOI - PubMed
-
- Mastenbroek MH, Versteeg H, Jordaens L, Theuns DA, Pedersen SS. Ventricular tachyarrhythmias and mortality in patients with an implantable cardioverter defibrillator: impact of depression in the MIDAS cohort. Psychosom Med. 2014;76(1):58–65. https://doi.org/10.1097/PSY.0000000000000017 . - DOI - PubMed
-
- •• Szpakowski N, Qiu F, Masih S, Kurdyak P, Wijeysundera HC. Economic impact of subsequent depression in patients with a new diagnosis of stable angina: a population-based study. J Am Heart Assoc. 2017;6(10). https://doi.org/10.1161/JAHA.117.006911 . Findings from this study show that patients with heart disease and comorbid depression cost society 33% more than patients with heart disease alone.
-
- Pedersen SS, von Kanel R, Tully PJ, Denollet J. Psychosocial perspectives in cardiovascular disease. Eur J Prev Cardiol. 2017;24(3_suppl):108–15. https://doi.org/10.1177/2047487317703827 .
Publication types
MeSH terms
LinkOut - more resources
Full Text Sources
Research Materials
